Kaas RS , Friis C, Ussery DW, Aarestrup FM: Estimating variation within the genes and inferring the phylogeny of 186 sequenced diverse Escherichia coli genomes. BMC Genomics 13, 577 (2012)

Kaas RS , FriisC, UsseryDW, AarestrupFM: Estimating variation within the genes and inferring the phylogeny of 186 sequenced diverse Escherichia coli genomes. BMC Genomics13, 577 (2012))| false
• Search Google Scholar
• Export Citation

Tannock GW (1995). Normal Microflora. An Introduction to Microbes Inhabiting the Human Body, Chapman and Hall, London, UK

Tannock GW (1995). Normal Microflora. An Introduction to Microbes Inhabiting the Human Body, Chapman and Hall, London, UK)| false
• Search Google Scholar
• Export Citation

Caugant DA , Levin BR, Selander RK: Genetic diversity and temporal variation in the E. coli population of a human host. Genetics 98, 467–490 (1981)

Caugant DA , LevinBR, SelanderRK: Genetic diversity and temporal variation in the E. coli population of a human host. Genetics98, 467–490 (1981))| false
• Search Google Scholar
• Export Citation

Sender R , Fuchs S, Milo R: Revised estimates for the number of human and bacteria cells in the body. Plos Biol 14(8), e1002533 (2016)

Sender R , FuchsS, MiloR: Revised estimates for the number of human and bacteria cells in the body. Plos Biol14(8), e1002533 (2016))| false
• Search Google Scholar
• Export Citation

Hill MJ , Drasar BS: The normal colonic bacterial flora. Gut 16, 318–323 (1975)

Hill MJ , DrasarBS: The normal colonic bacterial flora. Gut16, 318–323 (1975))| false
• Search Google Scholar
• Export Citation

Zuo HJ , Xie ZM, Zhang WW, Li YR, Wang W, Ding XB, Pei XF: Gut bacteria alteration in obese people and its relationship with gene polymorphism. World, J Gastroenterol 17, 1076–1081 (2011)

Zuo HJ , XieZM, ZhangWW, LiYR, WangW, DingXB, PeiXF: Gut bacteria alteration in obese people and its relationship with gene polymorphism. World, J Gastroenterol17, 1076–1081 (2011))| false
• Search Google Scholar
• Export Citation

Lagier JC , Hugon P, Khelaifia S, Fournier PE, La Scola B, Raoult D: The rebirth of culture in microbiology through the example of culturomics to study human gut microbiota. Clin Microbiol Rev 28, 237–264 (2015)

Lagier JC , HugonP, KhelaifiaS, FournierPE, La ScolaB, RaoultD: The rebirth of culture in microbiology through the example of culturomics to study human gut microbiota. Clin Microbiol Rev28, 237–264 (2015))| false
• Search Google Scholar
• Export Citation

Avershina E , Rudi K: Confusion about the species richness of human gut microbiota. Benef Microbes 6, 657–659 (2015)

Avershina E , RudiK: Confusion about the species richness of human gut microbiota. Benef Microbes6, 657–659 (2015))| false
• Search Google Scholar
• Export Citation

Qin J , Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Doré J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J; MetaHIT Consortium, Bork P, Ehrlich SD, Wang J: A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59–65 (2010)

Qin J , LiR, RaesJ, ArumugamM, BurgdorfKS, ManichanhC, NielsenT, PonsN, LevenezF, YamadaT, MendeDR, LiJ, XuJ, LiS, LiD, CaoJ, WangB, LiangH, ZhengH, XieY, TapJ, LepageP, BertalanM, BattoJM, HansenT, Le PaslierD, LinnebergA, NielsenHB, PelletierE, RenaultP, Sicheritz-PontenT, TurnerK, ZhuH, YuC, LiS, JianM, ZhouY, LiY, ZhangX, LiS, QinN, YangH, WangJ, BrunakS, Doré J, GuarnerF, KristiansenK, PedersenO, ParkhillJ, WeissenbachJ; MetaHIT Consortium, BorkP, EhrlichSD, WangJ: A human gut microbial gene catalogue established by metagenomic sequencing. Nature464, 59–65 (2010))| false
• Search Google Scholar
• Export Citation

Lodinová-Zádníková R , Sonnenborn U, Tlaskalová H: Probiotics and E. coli infections in man. Vet Q 20 Suppl 3, S78–81 (1998)

Lodinová-Zádníková R , SonnenbornU, TlaskalováH: Probiotics and E. coli infections in man. Vet Q20 Suppl 3, S78–81 (1998))| false
• Search Google Scholar
• Export Citation

Sheshko V , Hejnova J, Rehakova Z, Sinkora J, Faldyna M, Alexa P, Felsberg J, Nemcova R, Bomba A, Sebo P: HlyA knock out yields a safer Escherichia coli A0 34/86 variant with unaffected colonization capacity in piglets. FEMS Immunol Med Microbiol 48, 257–266 (2006)

Sheshko V , HejnovaJ, RehakovaZ, SinkoraJ, FaldynaM, AlexaP, FelsbergJ, NemcovaR, BombaA, SeboP: HlyA knock out yields a safer Escherichia coli A0 34/86 variant with unaffected colonization capacity in piglets. FEMS Immunol Med Microbiol48, 257–266 (2006))| false
• Search Google Scholar
• Export Citation

Lodinová R , Jouja V, Lanc A: Influence of the intestinal flora on the development of immune reactions in infants. J Bacteriol 93, 797–800 (1967)

Lodinová R , JoujaV, LancA: Influence of the intestinal flora on the development of immune reactions in infants. J Bacteriol93, 797–800 (1967))| false
• Search Google Scholar
• Export Citation

Lodinová R , Jouja V, Lanc A: Experimentelle Besiedlung des Darmtrakts von Neugeborenen mit dem E. coli 083 und Untersuchungen über die Bildung von Antikorpern. Z Immunitaetsforsch 133, 229–237 (1967)

Lodinová R , JoujaV, LancA: Experimentelle Besiedlung des Darmtrakts von Neugeborenen mit dem E. coli 083 und Untersuchungen über die Bildung von Antikorpern. Z Immunitaetsforsch133, 229–237 (1967))| false
• Search Google Scholar
• Export Citation

Lodinová R , Wagner V: Development of faecal immunoglobulins and coproantibodies in infants after artificial oral colonization with E. coli 083. Experientia 26, 188 (1970)

Lodinová R , WagnerV: Development of faecal immunoglobulins and coproantibodies in infants after artificial oral colonization with E. coli 083. Experientia26, 188 (1970))| false
• Search Google Scholar
• Export Citation

Lodinová-Zádníková R , Slavíková M, Tlaskalová-Hogenová H, Adlerberth I, Hanson LA, Wold A, Carlsson B, Svanborg C, Mellander L: The antibody response in breastfed and non-breast-fed infants after artificial colonization of the intestine with Escherichia coli O83. Pediatr Res 29, 396–399 (1991)

Lodinová-Zádníková R , SlavíkováM, Tlaskalová-HogenováH, AdlerberthI, HansonLA, WoldA, CarlssonB, SvanborgC, MellanderL: The antibody response in breastfed and non-breast-fed infants after artificial colonization of the intestine with Escherichia coli O83. Pediatr Res29, 396–399 (1991))| false
• Search Google Scholar
• Export Citation

Lodinová-Zádníková R , Prokesová L, Tlaskalová H, Kocourková I, Zizka J, Stranák Z: Influence of oral colonization with probiotic E. coli strain after birth on frequency of recurrent infections, allergy and development of some immunologic parameters. Long-term studies. Ceska Gynekol 69 Suppl 1, 91–97 (2004)

Lodinová-Zádníková R , ProkesováL, TlaskalováH, KocourkováI, ZizkaJ, StranákZ: Influence of oral colonization with probiotic E. coli strain after birth on frequency of recurrent infections, allergy and development of some immunologic parameters. Long-term studies. Ceska Gynekol 69 Suppl1, 91–97 (2004))| false
• Search Google Scholar
• Export Citation

Kocourková I , Žádníková R, Žižka J, Rosová V: Effect of oral application of a probiotic E. coli strain on the intestinal microbiota of children of allergic mothers during the first year of life. Folia Microbiol (Praha) 52, 189–193 (2007)

Kocourková I , ŽádníkováR, ŽižkaJ, RosováV: Effect of oral application of a probiotic E. coli strain on the intestinal microbiota of children of allergic mothers during the first year of life. Folia Microbiol (Praha)52, 189–193 (2007))| false
• Search Google Scholar
• Export Citation

Lodinová-Zádníková R , Cukrovská B, Stranák Z: Effect of care in a protected environment on the occurrence of nosocomial infections, mucosal colonization of pathogenic microbiota and development of indicators of immunity in premature infants. Ceska Gynekol 67 Suppl 1, 23–28 (2002)

Lodinová-Zádníková R , CukrovskáB, StranákZ: Effect of care in a protected environment on the occurrence of nosocomial infections, mucosal colonization of pathogenic microbiota and development of indicators of immunity in premature infants. Ceska Gynekol 67 Suppl1, 23–28 (2002))| false
• Search Google Scholar
• Export Citation

Hejnova J , Pages D, Rusniok C, Glaser P, Sebo P, Buchrieser C: Specific regions of genome plasticity and genetic diversity of the commensal Escherichia coli A0 34/86. Int, J Med Microbiol 296, 541–546 (2006)

Hejnova J , PagesD, RusniokC, GlaserP, SeboP, BuchrieserC: Specific regions of genome plasticity and genetic diversity of the commensal Escherichia coli A0 34/86. Int, J Med Microbiol296, 541–546 (2006))| false
• Search Google Scholar
• Export Citation

Jansen GJ , Wildeboer-Veloo AC, van der Waaij D, Degener JE: Escherichia coli as a probiotic? Infection 26, 232–233 (1998)

Jansen GJ , Wildeboer-VelooAC, van der WaaijD, DegenerJE: Escherichia coli as a probiotic?Infection26, 232–233 (1998))| false
• Search Google Scholar
• Export Citation

Möndel M , Schroeder BO, Zimmermann K, Huber H, Nuding S, Beisner J, Fellermann K, Stange EF, Wehkamp J: Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans. Mucosal Immunol 2, 166–172 (2009)

Möndel M , SchroederBO, ZimmermannK, HuberH, NudingS, BeisnerJ, FellermannK, StangeEF, WehkampJ: Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans. Mucosal Immunol2, 166–172 (2009))| false
• Search Google Scholar
• Export Citation

Enck P , Zimmermann K, Menke G, Klosterhalfen S: Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E. coli preparation (DSM17252) compared to placebo. Z Gastroenterol 47, 209–214. (2009) Erratum in Z Gastroenterol 52, 64 (2014)

Enck P , ZimmermannK, MenkeG, KlosterhalfenS: Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E. coli preparation (DSM17252) compared to placebo. Z Gastroenterol 47, 209–214. (2009) Erratum in Z Gastroenterol52, 64 (2014))| false
• Search Google Scholar
• Export Citation

Martens U , Enck P, Zieseniss E: Probiotic treatment of irritable bowel syndrome in children. Ger Med Sci 8, Doc07 (2010)

Martens U , EnckP, ZiesenissE: Probiotic treatment of irritable bowel syndrome in children. Ger Med Sci8, Doc07 (2010))| false
• Search Google Scholar
• Export Citation

Kruis W , Chrubasik S, Boehm S, Stange C, Schulze J: A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome. Int, J Colorectal Dis 27, 467–474 (2012)

Kruis W , ChrubasikS, BoehmS, StangeC, SchulzeJ: A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome. Int, J Colorectal Dis27, 467–474 (2012))| false
• Search Google Scholar
• Export Citation

Ford AC , Quigley EM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM, Moayyedi P: Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am, J Gastroenterol 109, 1547–1561 (2014)

Ford AC , QuigleyEM, LacyBE, LemboAJ, SaitoYA, SchillerLR, SofferEE, SpiegelBM, MoayyediP: Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am, J Gastroenterol109, 1547–1561 (2014))| false
• Search Google Scholar
• Export Citation

Wassenaar TM , Beimfohr C, Geske T, Zimmermann K: Voluntarily exposure to a single, high dose of probiotic Escherichia coli results in prolonged colonisation. Benef Microbes 5, 367–375 (2014)

Wassenaar TM , BeimfohrC, GeskeT, ZimmermannK: Voluntarily exposure to a single, high dose of probiotic Escherichia coli results in prolonged colonisation. Benef Microbes5, 367–375 (2014))| false
• Search Google Scholar
• Export Citation

Wassenaar TM , Zschüttig A, Beimfohr C, Geske T, Auerbach C, Cook H, Zimmermann K, Gunzer F: Virulence genes in a probiotic E. coli product with a recorded long history of safe use. Eur, J Microbiol Immunol (Bp) 5, 81–93 (2015)

Wassenaar TM , Zschüttig A, BeimfohrC, GeskeT, AuerbachC, CookH, ZimmermannK, GunzerF: Virulence genes in a probiotic E. coli product with a recorded long history of safe use. Eur, J Microbiol Immunol (Bp)5, 81–93 (2015))| false
• Search Google Scholar
• Export Citation

Schütz E : Behandlung von Darmerkrankungen mit Mutaflor. Fortschr Med 107, 599–602 (1989)

Schütz E : Behandlung von Darmerkrankungen mit Mutaflor. Fortschr Med107, 599–602 (1989))| false
• Search Google Scholar
• Export Citation

Kruis W , Schütz E, Fric P, Fixa B, Judmaier G, Stolte M: Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 11, 853–858 (1997)

Kruis W , Schütz E, FricP, FixaB, JudmaierG, StolteM: Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther11, 853–858 (1997))| false
• Search Google Scholar
• Export Citation

Rembacken BJ , Snelling AM, Hawkey PM, Chalmers DM, Axon AT: Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet, 354, 635–639 (1999)

Rembacken BJ , SnellingAM, HawkeyPM, ChalmersDM, AxonAT: Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet,354, 635–639 (1999))| false
• Search Google Scholar
• Export Citation

Kruis W , Fric P, Pokrotnieks J, Lukás M, Fixa B, Kascák M, Kamm MA, Weismueller J, Beglinger C, Stolte M, Wolff C, Schulze J: Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53, 1617–1623 (2004)

Kruis W , FricP, PokrotnieksJ, LukásM, FixaB, KascákM, KammMA, WeismuellerJ, BeglingerC, StolteM, WolffC, SchulzeJ: Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut53, 1617–1623 (2004))| false
• Search Google Scholar
• Export Citation

Goel A , Mittal A, Evstatiev R, Nemeth M, Kruis W, Stolte M, Boland CR, Gasche C: In vivo effects of mesalazine or E. coli Nissle 1917 on microsatellite instability in ulcerative colitis. Aliment Pharmacol Ther 30, 634–642 (2009)

Goel A , MittalA, EvstatievR, NemethM, KruisW, StolteM, BolandCR, GascheC: In vivo effects of mesalazine or E. coli Nissle 1917 on microsatellite instability in ulcerative colitis. Aliment Pharmacol Ther30, 634–642 (2009))| false
• Search Google Scholar
• Export Citation

Henker J , Müller S, Laass MW, Schreiner A, Schulze J: Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study. Z Gastroenterol 46, 874–875 (2008)

Henker J , Müller S, LaassMW, SchreinerA, SchulzeJ: Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study. Z Gastroenterol46, 874–875 (2008))| false
• Search Google Scholar
• Export Citation

Matthes H , Krummenerl T, Giensch M, Wolff C, Schulze J: Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN). BMC Complement Altern Med 10, 13 (2010)

Matthes H , KrummenerlT, GienschM, WolffC, SchulzeJ: Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN). BMC Complement Altern Med10, 13 (2010))| false
• Search Google Scholar
• Export Citation

Joeres-Nguyen-Xuan TH , Boehm SK, Joeres L, Schulze J, Kruis W: Survival of the probiotic Escherichia coli Nissle 1917 (EcN) in the gastrointestinal tract given in combination with oral mesalamine to healthy volunteers. Inflamm Bowel Dis 16, 256–262 (2010)

Joeres-Nguyen-Xuan TH , BoehmSK, JoeresL, SchulzeJ, KruisW: Survival of the probiotic Escherichia coli Nissle 1917 (EcN) in the gastrointestinal tract given in combination with oral mesalamine to healthy volunteers. Inflamm Bowel Dis16, 256–262 (2010))| false
• Search Google Scholar
• Export Citation

Petersen AM , Mirsepasi H, Halkjær SI, Mortensen EM, Nordgaard-Lassen I, Krogfelt KA: Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial. J Crohns Colitis 8, 1498–1505 (2014)

Petersen AM , MirsepasiH, Halkjær SI, MortensenEM, Nordgaard-LassenI, KrogfeltKA: Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial. J Crohns Colitis8, 1498–1505 (2014))| false
• Search Google Scholar
• Export Citation

Rolfe VE , Fortun PJ, Hawkey CJ, Bath-Hextall F: Probiotics for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev 4, CD004826 (2006)

Rolfe VE , FortunPJ, HawkeyCJ, Bath-HextallF: Probiotics for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev4, CD004826 (2006))| false
• Search Google Scholar
• Export Citation

Malchow HA : Crohn’s disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn’s disease? J Clin Gastroenterol 25, 653–658 (1997)

Malchow HA : Crohn’s disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn’s disease?J Clin Gastroenterol25, 653–658 (1997))| false
• Search Google Scholar
• Export Citation

Jensen SR , Fink LN, Nielsen OH, Brynskov J, Brix S: Ex vivo intestinal adhesion of Escherichia coli LF82 in Crohn’s disease. Microb Pathog 51, 426–431 (2011)

Jensen SR , FinkLN, NielsenOH, BrynskovJ, BrixS: Ex vivo intestinal adhesion of Escherichia coli LF82 in Crohn’s disease. Microb Pathog51, 426–431 (2011))| false
• Search Google Scholar
• Export Citation

Hernando-Harder AC , von Bünau R, Nadarajah M, Singer MV, Harder H: Influence of E. coli strain Nissle 1917 (EcN) on intestinal gas dynamics and abdominal sensation. Dig Dis Sci 53, 443–450 (2008)

Hernando-Harder AC , von BünauR, NadarajahM, SingerMV, HarderH: Influence of E. coli strain Nissle 1917 (EcN) on intestinal gas dynamics and abdominal sensation. Dig Dis Sci53, 443–450 (2008))| false
• Search Google Scholar
• Export Citation

Möllenbrink M , Bruckschen E: Behandlung der chronischen Obstipation mit physiologischen Escherichia coli-Bakterien. Ergebnisse einer klinischen Studie die Wirksamkeit und Verträglichkeit von mikrobiologischen The ra pie mit dem E. coli Stamm Nissle 1917 (Mutaflor). Med Klin (Munich) 89, 587–593 (1994)

Möllenbrink M , BruckschenE: Behandlung der chronischen Obstipation mit physiologischen Escherichia coli-Bakterien. Ergebnisse einer klinischen Studie die Wirksamkeit und Verträglichkeit von mikrobiologischen The ra pie mit dem E. coli Stamm Nissle 1917 (Mutaflor). Med Klin (Munich)89, 587–593 (1994))| false
• Search Google Scholar
• Export Citation

Lata J , Juránková J, Príbramská V, Fric P, Senkyrík M, Díte P, Kroupa R: Effect of administration of Escherichia coli Nissle (Mutaflor) on intestinal colonisation, endo-toxemia, liver function and minimal hepatic encephalopathy in patients with liver cirrhosis. Vnitr Lek 52, 215–219 (2006)

Lata J , Juránková J, Príbramská V, FricP, SenkyríkM, DíteP, KroupaR: Effect of administration of Escherichia coli Nissle (Mutaflor) on intestinal colonisation, endo-toxemia, liver function and minimal hepatic encephalopathy in patients with liver cirrhosis. Vnitr Lek52, 215–219 (2006))| false
• Search Google Scholar
• Export Citation

Lata J , Novotný I, Príbramská V, Juránková J, Fric P, Kroupa R, Stiburek O: The effect of probiotics on gut flora, level of endotoxin and Child–Pugh score in cirrhotic patients: results of a double-blind randomized study. Eur, J Gastroenterol Hepatol 19, 1111–1113 (2007)

Lata J , Novotný I, Príbramská V, Juránková J, FricP, KroupaR, StiburekO: The effect of probiotics on gut flora, level of endotoxin and Child–Pugh score in cirrhotic patients: results of a double-blind randomized study. Eur, J Gastroenterol Hepatol19, 1111–1113 (2007))| false
• Search Google Scholar
• Export Citation

Fric P , Zavoral M: The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Eur, J Gastroenterol Hepatol 15, 313–315 (2003)

Fric P , ZavoralM: The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Eur, J Gastroenterol Hepatol15, 313–315 (2003))| false
• Search Google Scholar
• Export Citation

Tromm A , Niewerth U, Khoury M, Baestlein E, Wilhelms G, Schulze J, Stolte M: The probiotic E. coli strain Nissle 1917 for the treatment of collagenous colitis: first results of an open-label trial. Z Gastroenterol 42, 365–369 (2004)

Tromm A , NiewerthU, KhouryM, BaestleinE, WilhelmsG, SchulzeJ, StolteM: The probiotic E. coli strain Nissle 1917 for the treatment of collagenous colitis: first results of an open-label trial. Z Gastroenterol42, 365–369 (2004))| false
• Search Google Scholar
• Export Citation

Lodinová-Zádniková R , Sonnenborn U: Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants. Biol Neonate 71, 224–232 (1997)

Lodinová-Zádniková R , SonnenbornU: Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants. Biol Neonate71, 224–232 (1997))| false
• Search Google Scholar
• Export Citation

Cukrowska B , LodInová-ZádnIková R, Enders C, Sonnenborn U, Schulze J, Tlaskalová-Hogenová H: Specific proliferative and antibody responses of premature infants to intestinal colonization with nonpathogenic probiotic E. coli strain Nissle 1917. Scand, J Immunol 55, 204–209 (2002)

Cukrowska B , LodInová-ZádnIkováR, EndersC, SonnenbornU, SchulzeJ, Tlaskalová-HogenováH: Specific proliferative and antibody responses of premature infants to intestinal colonization with nonpathogenic probiotic E. coli strain Nissle 1917. Scand, J Immunol55, 204–209 (2002))| false
• Search Google Scholar
• Export Citation

Henker J , Laass M, Blokhin BM, Bolbot YK, Maydannik VG, Elze M, Wolff C, Schulze J: The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers. Eur, J Pediatr 166, 311–318 (2007)

Henker J , LaassM, BlokhinBM, BolbotYK, MaydannikVG, ElzeM, WolffC, SchulzeJ: The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers. Eur, J Pediatr166, 311–318 (2007))| false
• Search Google Scholar
• Export Citation

Goerg KJ , Schlörer E: Probiotische Therapie einer pseudomembranösen Kolitis: Kombination aus intestinaler Lavage und oraler Gabe von Escherichia coli. Dtsch Med Wochenschr 123, 1274–1278 (1998)

Goerg KJ , SchlörerE: Probiotische Therapie einer pseudomembranösen Kolitis: Kombination aus intestinaler Lavage und oraler Gabe von Escherichia coli. Dtsch Med Wochenschr123, 1274–1278 (1998))| false
• Search Google Scholar
• Export Citation

Dölle S , Berg J, Rasche C, Worm M: Tolerability and clinical outcome of coseasonal treatment with Escherichia coli strain Nissle 1917 in grass pollen-allergic subjects. Int Arch Allergy Immunol 163, 29–35 (2014)

Dölle S , BergJ, RascheC, WormM: Tolerability and clinical outcome of coseasonal treatment with Escherichia coli strain Nissle 1917 in grass pollen-allergic subjects. Int Arch Allergy Immunol163, 29–35 (2014))| false
• Search Google Scholar
• Export Citation

Tannock GW , Tiong IS, Priest P, Munro K, Taylor C, Richardson A, Schultz M: Testing probiotic strain Escherichia coli Nissle 1917 (Mutaflor) for its ability to reduce carriage of multidrug-resistant E. coli by elderly residents in longterm care facilities. J Med Microbiol 60, 366–370 (2011)

Tannock GW , TiongIS, PriestP, MunroK, TaylorC, RichardsonA, SchultzM: Testing probiotic strain Escherichia coli Nissle 1917 (Mutaflor) for its ability to reduce carriage of multidrug-resistant E. coli by elderly residents in longterm care facilities. J Med Microbiol60, 366–370 (2011))| false
• Search Google Scholar
• Export Citation

Prilassnig M , Wenisch C, Daxboeck F, Feierl G: Are probiotics detectable in human feces after oral uptake by healthy volunteers? Wien Klin Wochenschr 119, 456–462 (2007)

Prilassnig M , WenischC, DaxboeckF, FeierlG: Are probiotics detectable in human feces after oral uptake by healthy volunteers?Wien Klin Wochenschr119, 456–462 (2007))| false
• Search Google Scholar
• Export Citation

Adediran J , Leatham-Jensen MP, Mokszycki ME, Frimodt-Møller J, Krogfelt KA, Kazmierczak K, Kenney LJ, Conway T, Cohen PS: An Escherichia coli Nissle 1917 missense mutant colonizes the streptomycin-treated mouse intestine better than the wild type but is not a better probiotic. Infect Immun 82, 670–682 (2014)

Adediran J , Leatham-JensenMP, MokszyckiME, Frimodt-MøllerJ, KrogfeltKA, KazmierczakK, KenneyLJ, ConwayT, CohenPS: An Escherichia coli Nissle 1917 missense mutant colonizes the streptomycin-treated mouse intestine better than the wild type but is not a better probiotic. Infect Immun82, 670–682 (2014))| false
• Search Google Scholar
• Export Citation

Lochs H : A question of survival? Interaction between probiotics and the gastrointestinal tract. Wien Klin Wochenschr 119, 441–443 (2007)

Lochs H : A question of survival? Interaction between probiotics and the gastrointestinal tract. Wien Klin Wochenschr119, 441–443 (2007))| false
• Search Google Scholar
• Export Citation

Caselli M , Cassol F, Calò G, Holton J, Zuliani G, Gasbarrini A: Actual concept of “probiotics”: is it more functional to science or business? World, J Gastroenterol 19, 1527–1540 (2013)

Caselli M , CassolF, CalòG, HoltonJ, ZulianiG, GasbarriniA: Actual concept of “probiotics”: is it more functional to science or business?World, J Gastroenterol19, 1527–1540 (2013))| false
• Search Google Scholar
• Export Citation

Reister M , Hoffmeier K, Krezdorn N, Rotter B, Liang C, Rund S, Dandekar T, Sonnenborn U, Oelschlaeger TA: Complete genome sequence of the gram-negative probiotic Escherichia coli strain Nissle 1917. J Biotechnol 187, 106–107 (2014)

Reister M , HoffmeierK, KrezdornN, RotterB, LiangC, RundS, DandekarT, SonnenbornU, OelschlaegerTA: Complete genome sequence of the gram-negative probiotic Escherichia coli strain Nissle 1917. J Biotechnol187, 106–107 (2014))| false
• Search Google Scholar
• Export Citation

Cress BF , Linhardt RJ, Koffas MA: Draft genome sequence of Escherichia coli strain Nissle 1917 (Serovar O6:K5:H1). Genome Announc, 28, 1(2), e0004713 (2013)

Cress BF , LinhardtRJ, KoffasMA: Draft genome sequence of Escherichia coli strain Nissle 1917 (Serovar O6:K5:H1). Genome Announc,28, 1(2), e0004713 (2013))| false
• Search Google Scholar
• Export Citation

Jacobi CA , Malfertheiner P: Escherichia coli Nissle 1917 (Mutaflor): new insights into an old probiotic bacterium. Dig Dis 29, 600–607 (2011)

Jacobi CA , MalfertheinerP: Escherichia coli Nissle 1917 (Mutaflor): new insights into an old probiotic bacterium. Dig Dis29, 600–607 (2011))| false
• Search Google Scholar
• Export Citation

Verna EC , Lucak S: Use of probiotics in gastrointestinal disorders: what to recommend? Therap Adv Gastroenterol 3, 307–319 (2010)

Verna EC , LucakS: Use of probiotics in gastrointestinal disorders: what to recommend?Therap Adv Gastroenterol3, 307–319 (2010))| false
• Search Google Scholar
• Export Citation

Nissle A : Über die Grundlagen einer neuen ursächlichen Bekämpfung der pathologischen Darmflora. Deutsche Medizinische Wochenschrift 42, 1181–1184 (1916)

Nissle A : Über die Grundlagen einer neuen ursächlichen Bekämpfung der pathologischen Darmflora. Deutsche Medizinische Wochenschrift42, 1181–1184 (1916))| false
• Search Google Scholar
• Export Citation

Pöhlmann C , Thomas M, Förster S, Brandt M, Hartmann M, Bleich A, Gunzer F: Improving health from the inside: use of engineered intestinal microorganisms as in situ cytokine delivery system. Bioengineered 4, 172–179 (2013)

Pöhlmann C , ThomasM, FörsterS, BrandtM, HartmannM, BleichA, GunzerF: Improving health from the inside: use of engineered intestinal microorganisms as in situ cytokine delivery system. Bioengineered4, 172–179 (2013))| false
• Search Google Scholar
• Export Citation

Nissle A : Die antagonistische Behandlung chronischer Darmstörungen mit Colibakterien. Med Klin 2, 29–33 (1918)

Nissle A : Die antagonistische Behandlung chronischer Darmstörungen mit Colibakterien. Med Klin2, 29–33 (1918))| false
• Search Google Scholar
• Export Citation

Ortuño Sahagún D , Márquez-Aguirre AL, Quintero-Fabián S, López-Roa RI, Rojas-Mayorquín AE: Modulation of PPAR by nutraceutics as complementary treatment for obesity-related disorders and inflammatory diseases. PPAR Res 2012, 318613 (2012)

Ortuño Sahagún D , Márquez-AguirreAL, Quintero-FabiánS, López-RoaRI, Rojas-MayorquínAE: Modulation of PPAR by nutraceutics as complementary treatment for obesity-related disorders and inflammatory diseases. PPAR Res2012, 318613 (2012))| false
• Search Google Scholar
• Export Citation

Nissle A : Weiteres über Grundlagen und Praxis der Mutaflor-Behandlung. Deutsche Medizinische Wochenschrift 44, 1809–1813 (1925)

Nissle A : Weiteres über Grundlagen und Praxis der Mutaflor-Behandlung. Deutsche Medizinische Wochenschrift44, 1809–1813 (1925))| false
• Search Google Scholar
• Export Citation

Zyrek AA , Cichon C, Helms S, Enders C, Sonnenborn U, Schmidt MA: Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol 9, 804–816 (2007)

Zyrek AA , CichonC, HelmsS, EndersC, SonnenbornU, SchmidtMA: Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol9, 804–816 (2007))| false
• Search Google Scholar
• Export Citation

Nissle A : Weiteres ü ber die Mutaflorbehandlung unter besonderer Berü cksichtigung der chronischen Ruhr. Mü nchener Medizinische Wochenschrift 25, 678–681 (1919)

Nissle A : Weiteres ü ber die Mutaflorbehandlung unter besonderer Berü cksichtigung der chronischen Ruhr. Mü nchener Medizinische Wochenschrift25, 678–681 (1919))| false
• Search Google Scholar
• Export Citation

Nissle A : Erläuterung über die Bedeutung der Kolondysbakterie und den Wirkungsmechanismus der Colitherapie (“Mutaflor”). Die Medizinische 4, 1017–1022 (1959)

Nissle A : Erläuterung über die Bedeutung der Kolondysbakterie und den Wirkungsmechanismus der Colitherapie (“Mutaflor”). Die Medizinische4, 1017–1022 (1959))| false
• Search Google Scholar
• Export Citation

Nissle A : Alte und neue Erfahrungen über Heilerfolge durch Sanierung der Dickdarmflora mit Mutaflor bei Magen-Darmkrankheiten. Medizinische Welt 29–30, 1519–1523 (1961)

Nissle A : Alte und neue Erfahrungen über Heilerfolge durch Sanierung der Dickdarmflora mit Mutaflor bei Magen-Darmkrankheiten. Medizinische Welt29–30, 1519–1523 (1961))| false
• Search Google Scholar
• Export Citation

Nissle A : Zur Klärung der Beziehungen zwischen Krankheitsursache, Symptomen und rationeller Therapie. Medizinische Welt 23, 1290–1294 (1966)

Nissle A : Zur Klärung der Beziehungen zwischen Krankheitsursache, Symptomen und rationeller Therapie. Medizinische Welt23, 1290–1294 (1966))| false
• Search Google Scholar
• Export Citation

Tannock GW (2002): Probiotics and Prebiotics: Where are we going? Caister Academic Press, Norfolk, England

Tannock GW (2002): Probiotics and Prebiotics: Where are we going?Caister Academic Press, Norfolk, England)| false
• Search Google Scholar
• Export Citation

Fishbein M : The aerogenic response of Escherichia coli and strains of Aerobacter in EC broth and selected sugar broths at elevated temperatures. Appl Microbiol 10, 79–85 (1962)

Fishbein M : The aerogenic response of Escherichia coli and strains of Aerobacter in EC broth and selected sugar broths at elevated temperatures. Appl Microbiol10, 79–85 (1962))| false
• Search Google Scholar
• Export Citation

Vassiliadis G , Destoumieux-Garzón D, Lombard C, Rebuffat S, Peduzzi J: Isolation and characterization of two members of the siderophore-microcin family, microcins M and H47. Antimicrob Agents Chemother 54, 288–297 (2010)

Vassiliadis G , Destoumieux-Garzón D, LombardC, RebuffatS, PeduzziJ: Isolation and characterization of two members of the siderophore-microcin family, microcins M and H47. Antimicrob Agents Chemother54, 288–297 (2010))| false
• Search Google Scholar
• Export Citation

Barth S , Duncker S, Hempe J, Breves G, Baljer G, Bauerfeind R: Escherichia coli Nissle 1917 for probiotic use in piglets: evidence for intestinal colonization. J Appl Microbiol 107, 1697–1710 (2009)

Barth S , DunckerS, HempeJ, BrevesG, BaljerG, BauerfeindR: Escherichia coli Nissle 1917 for probiotic use in piglets: evidence for intestinal colonization. J Appl Microbiol107, 1697–1710 (2009))| false
• Search Google Scholar
• Export Citation

Kleta S , Steinrück H, Breves G, Duncker S, Laturnus C, Wieler LH, Schierack P: Detection and distribution of probiotic Escherichia coli Nissle 1917 clones in swine herds in Germany. J Appl Microbiol 101, 1357–1366 (2006)

Kleta S , Steinrück H, BrevesG, DunckerS, LaturnusC, WielerLH, SchierackP: Detection and distribution of probiotic Escherichia coli Nissle 1917 clones in swine herds in Germany. J Appl Microbiol101, 1357–1366 (2006))| false
• Search Google Scholar
• Export Citation

Schroeder B , Duncker S, Barth S, Bauerfeind R, Gruber AD, Deppenmeier S, Breves G: Preventive effects of the probiotic Escherichia coli strain Nissle 1917 on acute secretory diarrhea in a pig model of intestinal infection. Dig Dis Sci 51, 724–731 (2006)

Schroeder B , DunckerS, BarthS, BauerfeindR, GruberAD, DeppenmeierS, BrevesG: Preventive effects of the probiotic Escherichia coli strain Nissle 1917 on acute secretory diarrhea in a pig model of intestinal infection. Dig Dis Sci51, 724–731 (2006))| false
• Search Google Scholar
• Export Citation

Splichalova A , Trebichavsky I, Rada V, Vlkova E, Sonnenborn U, Splichal I: Interference of Bifidobacterium choerinum or Escherichia coli Nissle 1917 with Salmonella Typhimurium in gnotobiotic piglets correlates with cytokine patterns in blood and intestine. Clin Exp Immunol 163, 242–249 (2011)

Splichalova A , TrebichavskyI, RadaV, VlkovaE, SonnenbornU, SplichalI: Interference of Bifidobacterium choerinum or Escherichia coli Nissle 1917 with Salmonella Typhimurium in gnotobiotic piglets correlates with cytokine patterns in blood and intestine. Clin Exp Immunol163, 242–249 (2011))| false
• Search Google Scholar
• Export Citation

Schierack P , Kleta S, Tedin K, Babila JT, Oswald S, Oelschlaeger TA, Hiemann R, Paetzold S, Wieler LH: E. coli Nissle 1917 Affects Salmonella adhesion to porcine intestinal epithelial cells. PLoS One 6(2), e14712 (2011)

Schierack P , KletaS, TedinK, BabilaJT, OswaldS, OelschlaegerTA, HiemannR, PaetzoldS, WielerLH: E. coli Nissle 1917 Affects Salmonella adhesion to porcine intestinal epithelial cells. PLoS One6(2), e14712 (2011))| false
• Search Google Scholar
• Export Citation

Kleta S , Nordhoff M, Tedin K, Wieler LH, Kolenda R, Oswald S, Oelschlaeger TA, Bleiss W, Schierack P: Role of F1C fimbriae, flagella, and secreted bacterial components in the inhibitory effect of probiotic Escherichia coli Nissle 1917 on atypical enteropathogenic E. coli infection. Infect Immun 82, 1801–1802 (2014)

Kleta S , NordhoffM, TedinK, WielerLH, KolendaR, OswaldS, OelschlaegerTA, BleissW, SchierackP: Role of F1C fimbriae, flagella, and secreted bacterial components in the inhibitory effect of probiotic Escherichia coli Nissle 1917 on atypical enteropathogenic E. coli infection. Infect Immun82, 1801–1802 (2014))| false
• Search Google Scholar
• Export Citation

Bureš J , Smajs D, Kvetina J, Förstl M, Smarda J, Kohoutová D, Kuneš M, Cyrany J, Tacheci I, Rejchrt S, Lesná J, Vorisek V, Kopácová M: Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle. World, J Gastroenterol 17, 609–617 (2011)

Bureš J , SmajsD, KvetinaJ, FörstlM, SmardaJ, Kohoutová D, Kuneš M, CyranyJ, TacheciI, RejchrtS, Lesná J, VorisekV, KopácováM: Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle. World, J Gastroenterol17, 609–617 (2011))| false
• Search Google Scholar
• Export Citation

Bureš J , Pejchal J, Kvetina J, Tichý A, Rejchrt S, Kuneš M, Kopácová M: Morphometric analysis of the porcine gastrointestinal tract in a 10-day high-dose indomethacin administration with or without probiotic bacteria Escherichia coli Nissle 1917. Hum Exp Toxicol 30, 1955–1962 (2011)

Bureš J , PejchalJ, KvetinaJ, TichýA, RejchrtS, KunešM, KopácováM: Morphometric analysis of the porcine gastrointestinal tract in a 10-day high-dose indomethacin administration with or without probiotic bacteria Escherichia coli Nissle 1917. Hum Exp Toxicol30, 1955–1962 (2011))| false
• Search Google Scholar
• Export Citation

Smajs D , Bureš J, Smarda J, Chaloupková E, Kvetina J, Förstl M, Kohoutová D, Kuneš M, Rejchrt S, Lesná J, Kopácová M: Experimental administration of the probiotic Escherichia coli strain Nissle 1917 results in decreased diversity of E. coli strains in pigs. Curr Microbiol 64, 205–210 (2012)